DOI: 10.1212/WNL.0000000000004825

,  

,  

PMID: 29335307

Issn Print: 0028-3878

Publication Date: 2018/01/16


Print

Editors' note: A phase 3 trial of IV immunoglobulin for Alzheimer disease

Chafic Karam; Robert C. Griggs

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles